Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bortezomib
100%
Renoprotective Effect
100%
Adriamycin-induced Nephropathy
100%
Treatment Group
78%
Model Establishment
28%
Renal Tissue
21%
Serum Creatinine
14%
Albumin
14%
Collagen Type I
14%
Albumin-to-creatinine Ratio
14%
Tubulointerstitium
14%
Creatinine Blood
14%
Glomerulus
7%
Pathological Changes
7%
Fibrosis
7%
Immunohistochemistry
7%
Treatment Effect
7%
Adriamycin
7%
Collagen Deposition
7%
Intravenous Injection
7%
α-smooth muscle Actin (α-SMA)
7%
Blood Urea Nitrogen
7%
Heart Tissue
7%
Collagen Type III
7%
Glomerulosclerosis
7%
I-type
7%
Urinary Parameters
7%
Blood Parameters
7%
SD Rats
7%
Masson Staining
7%
PAS Staining
7%
Injury Index
7%
Blood Sampling
7%
Tissue Model
7%
Urinary Albumin-to-creatinine Ratio
7%
Blood Urea Nitrogen to Creatinine Ratio
7%
Deposition Area
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bortezomib
100%
Adriamycin-Induced Nephropathy
100%
Rat
100%
Treatment Group
78%
Creatinine
35%
Albumin
35%
Collagen Type 1
14%
Ureaplasma
14%
Nitrogen
14%
Fibrosis
7%
Doxorubicin
7%
Sprague Dawley Rat
7%
Smooth Muscle Actin
7%
Glomerulosclerosis
7%
Collagen Type 3
7%